ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,517, issued on April 7, was assigned to INSERM (INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), INSTITUTE DE CANCEROLOGIE DE L'OUEST (Angers, France) and NANTES UNIVERSITE (Nantes, France).

"Method to treat and stratify a patient suffering from a cancer" was invented by Pierre-Francois Cartron (Nantes Cedex 1, France) and Gwenola Bougras-Cartron (Nantes Cedex 1, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the stratification and treatment of patients suffering of cancer. Due to the fact that anti-PD1 therapy targets lymphocytes and the efficiency of anti-cancer therapy is measured by the...